Cynvenio Biosystems' Convertible Note - V Round

Cynvenio Biosystems raised a round of funding on October 31, 2017.

Cynvenio Biosystems, formerly CytomX, is focused on the development of the LiquidBiopsy platform, a high performance rare cell isolation technology for biomedical research and cancer diagnostics. Liqu…

Articles about Cynvenio Biosystems' Convertible Note - V Round: